Introduction {#s01}
============

Immunological memory is a cardinal feature of adaptive immunity that provides a significant survival advantage by protecting individuals from previously encountered pathogens ([@bib34]). Memory CD8 T cells have the potential to provide lifelong protection against pathogens containing their cognate epitope and are currently being exploited for strategies to protect against various intracellular pathogens and tumors. To achieve such long-lived protection, an adequate number of functionally competent memory CD8 T cells must be sustained in the absence of antigen through cytokine-driven homeostatic proliferation ([@bib44]; [@bib27]; [@bib48]; [@bib3], [@bib4]; [@bib16]; [@bib38]; [@bib23]). Such homeostasis-promoting cytokines enable a slow but continuous level of proliferation that does not appear to compromise the ability of memory CD8 T cells to rapidly recall their effector functions. Yet the cell-intrinsic mechanisms that maintain acquired memory-associated effector functions remain poorly defined.

A defining feature of T cell memory is the ability to rapidly transition from a quiescent state to a highly proliferative, cytolytic population of effector cells upon antigen reexposure ([@bib51]; [@bib43]). However, the specific capacity for mounting such a response in terms of proliferation, tissue homing, and recall of effector function is disproportionately attained by different subsets of memory T cells ([@bib18]; [@bib37]; [@bib15]). The phenotypic heterogeneity among the pool of memory T cells can be partitioned into subsets with distinct tissue homing and proliferative potential based on the expression of the lymphoid-homing chemokine receptor CCR7 ([@bib37]). Distinguished by a CCR7^+^ CD45RA^−^ phenotype, the now commonly termed central memory (T~CM~) subset of CD8 T cells has increased access to lymphoid tissue, whereas effector memory (T~EM~) CCR7^−^ CD45RA^−^ CD8 T cells home to nonlymphoid tissues ([@bib37]; [@bib30]; [@bib26]). Recently, a new subset of human memory CD8 T cells was identified based on expression of the surface markers CD95 and CD122. These memory T cells share many phenotypic properties with naive T cells, but unlike naive cells, they possess a heightened capacity to undergo IL-7-- and IL-15--driven homeostatic proliferation ([@bib15]). Moreover, this subset of memory cells exhibits the greatest level of cytokine-driven, homeostatic proliferation compared with that of other, more conventional, memory subsets. Given their tremendous ability to self-renew and give rise to other memory subsets, these cells are referred to as stem cell memory (T~SCM~) CD8 T cells.

Similar to stem cells, memory CD8 T cells face the challenge of balancing cell-fate stability, which is required for long-term homeostasis of subset specification, with the plasticity required for antigen-triggered cell differentiation during a recall response. Several studies addressing the underlying mechanisms of memory T cell differentiation have revealed that many of the phenotypic and functional adaptations among memory T cell subsets manifest at the level of transcriptional regulation ([@bib15]; [@bib39]; [@bib42]). For instance, the poised ability to recall effector molecules, including IFNγ, perforin (Prf1), and granzyme B (GzmB), is accompanied by either a sustained, elevated level of transcription in the resting memory cells and/or a rapid induction of transcription upon TCR signaling ([@bib45]). The poised state of these loci in memory CD8 T cells has been associated with an increased level of trimethylation of the H3K4 (permissive mark) and H3K27 (repressive mark) histones near the gene transcriptional start site ([@bib1]; [@bib45]; [@bib36]), yet whether these epigenetic programs are sustained during homeostatic self-renewal remains unclear.

Maintenance of acquired transcriptional programming in a dividing population of differentiated cells is mediated through epigenetic modifications. Specifically, CpG DNA methylation and histone modification promote and maintain changes in chromatin accessibility that control transcriptional permissibility ([@bib12]; [@bib1]). Although recent genome-wide studies of human memory CD8 T cells have reported specific correlations between gene expression and the density of different histone modifications ([@bib1]; [@bib11]), mounting evidence in other model systems suggests that DNA-methylation programming is a primary mediator for preserving transcriptionally repressive and permissive chromatin states in cells that have undergone several rounds of division ([@bib24]; [@bib21]; [@bib6]).

To determine whether changes in DNA methylation are coupled to the establishment and maintenance of memory-associated programs in human CD8 T cells, we performed a whole-genome assessment of DNA-methylation patterns in freshly isolated human naive and memory CD8 T cell subsets and tracked the stability of memory-associated epigenetic programs during in vitro cytokine-driven homeostatic proliferation and in vivo after infusion of haploidentical memory T cells into transplant patients. Here we show that human memory CD8 T cell--associated DNA methylation programs can be maintained during antigen-independent self-renewal. These data provide new insight into the molecular mechanism for maintenance of acquired functions in memory CD8 T cells during homeostasis and the future design of therapies to manipulate the antiviral and antitumor activities of those cells.

Results and discussion {#s02}
======================

Human memory CD8 T cell differentiation is coupled to subset-specific changes in DNA methylation {#s03}
------------------------------------------------------------------------------------------------

Homeostatic proliferation of memory CD8 T cells ensures preservation of T cell--based immunity by maintenance of a poised effector response for a long period of time. Maintenance of this state of readiness during cell division suggests the presence of a stable epigenetic mechanism, such as DNA methylation. However, it remains unclear whether DNA methylation programs acquired in long-lived memory CD8 T cells are maintained during antigen-independent proliferation. To determine whether memory-associated DNA methylation programs are maintained during homeostasis, we first sought to define bona fide memory subset-specific DNA methylation programs by performing whole-genome bisulfite sequencing (WGBS) of freshly isolated human naive and memory CD8 T cell subsets ([Fig. 1 A](#fig1){ref-type="fig"}).

![**Genome-wide changes in DNA-methylation programming are coupled to human memory CD8 T cell subset--specific differentiation.** (A) Flow cytometry--based strategy for isolating a sufficient quantity of naive and memory CD8 T cell subsets from apheresis blood unit of healthy donors for phenotypic, functional, and whole-genome epigenetic characterization. The cell subsets were identified based on the expression of three cell surface markers as follows: naive: CCR7^+^, CD45RO^−^, and CD95^−^; T~EM~: CCR7^−^ and CD45RO^+^; T~CM~: CCR7^+^ and CD45RO^+^; T~SCM~: CCR7^+^, CD45RO^−^, and CD95^+^. (B) Circos plot showing DNA methylation levels for naive and memory CD8 T cell subsets across the whole genome from two donors. CpG methylation levels were averaged over 10-Mb genomic intervals and are represented as histogram tracks. Heat map shows changes in the levels of DNA methylation with respect to the sample across the entire genome. Dark red indicates high levels of methylation, and light red indicates low levels of methylation. Dotted black circle separates two methylation patterns: dark red (high methylation, as in naive and T~SCM~) and light red (low methylation, as in T~CM~ and T~EM~). (C) PCA of methylation status of total CpGs with more than five times the coverage. (D) Summary graph of the number of methylated and demethylated regions in the T~EM~, T~CM~, and T~SCM~ genomes relative to that in the naive CD8^+^ T cell genome. The number of demethylated regions was calculated based on difference ≥30% methylation between two populations. The number of methylated regions was calculated based on ≤30% methylation difference between the two populations. (E) Pie charts showing the percentage of demethylated and methylated regions across the genomes of T~EM~, T~CM~, and T~SCM~ cells relative to that of naive CD8 T cells. (F) Normalized plot of CpG methylation at sites surrounding and within DMRs of effector molecules (*IFNγ*, *PRF1*, *GZMB*, and *GZMK*), tissue-homing molecules (CD62L and *CCR7*), and transcription factors (*T-BET* and *EOMES*) obtained from WGBS analysis. Red and blue lines depict methylation and demethylation of CpG sites, respectively.](JEM_20161760_Fig1){#fig1}

Our initial assessment of genome-wide DNA methylation levels revealed that the overall number of methylated CpGs was inversely correlated with the established differentiation state of these cells: naive \> T~SCM~ \> T~CM~ \> T~EM~. Moreover, the progressive decline in DNA methylation occurred across all autosomal chromosomes, indicating that effector and memory T cell differentiation is coupled to broad changes in DNA methylation (Fig. S1 B and [Fig. 1 B](#fig1){ref-type="fig"}). The variable levels of methylation among the long-lived versus short-lived memory CD8 T cell subsets prompted us to further assess the relationship between naive and memory CD8 T cell methylation profiles. An unsupervised principal component analysis (PCA) was performed on the methylation status of all CpG sites across the genome ([Fig. 1 C](#fig1){ref-type="fig"}). Clustering was observed among the naive replicates as well as among T~SCM~ replicates, but notably, the naive and T~SCM~ samples were found to be epigenetically distant (Fig. S1 C). Based on the methylation status at 9,377,480 CpGs (CpG sites with more than five times the sequencing coverage for every sample), we generated a dendrogram of all replicate samples. Calculation of Euclidean distances between each population in the dendrogram indicated that, despite the higher level of global DNA methylation, long-lived memory CD8 T cells (T~SCM~) have DNA methylation programs that are distinct from naive cells (Fig. S1 C).

To better define the DNA methylation programs that distinguish memory CD8 T cells from naive cells, we performed a pairwise comparison of naive versus memory cell WGBS datasets, identifying differences in DNA methylation at individual CpG sites across the genome. This comparison allowed us to define the number, distribution, and nature of differentially methylated regions (DMRs) between the genomes of naive and memory T cell subsets. We observed the greatest number of demethylated regions in T~EM~ cells relative to naive T cells ([Fig. 1 D](#fig1){ref-type="fig"}, top), further indicating that the T~EM~ memory subset is the most epigenetically distinct population from naive CD8 T cells ([Fig. 1 B](#fig1){ref-type="fig"} and Fig. S1 B). Regardless of the methylated-versus-demethylated status, most of the DMRs were enriched in the 5′-distal (1--50 kb) regions, suggesting an association with the transcriptional regulatory regions. These results prompted us to compare our WGBS data to the published histone profiles in human T~EM~ and T~CM~ CD8 T cells ([@bib1]). We found that these histone modifications (H3K4me3 and H3K27me3) only overlap with ∼75% of the DMRs (methylated and unmethylated). Importantly, the remaining 25% of the DMRs that did not overlap with the published histone modifications were enriched in the 5′ distal regions of genes (Fig. S1 D), which may represent enhancer elements. Indeed, a recent study by [@bib7] demonstrated the coexistence of CpG methylation and H3K27ac in enhancers outside transcription factor--binding sites and correlated this coexistence with a decrease in chromatin accessibility. Thus, the WGBS methylation data provided in this study reveal a comprehensive profile of genomic regions undergoing epigenetic reprogramming during human memory T cell differentiation.

Effector and memory-associated genes are targeted for DNA methylation reprogramming during differentiation of memory T cells {#s04}
----------------------------------------------------------------------------------------------------------------------------

We next sought to identify DNA methylation programs coupled to the unique properties of the individual memory T cell subsets. Again, a pairwise comparison of the methylation status among each memory subset was performed, and we detected 201,980, 62,240, and 9,026 DMRs unique to T~EM~, T~CM~, and T~SCM~ CD8 T cells, respectively (Fig. S1 E). Among the DMRs that delineate the T~EM~, T~CM~, and T~SCM~ CD8 T cells were subset-associated DMRs at CpG sites in the *CCR7* and CD62L (*SELL*) loci. Both *CCR7* and CD62L DMRs were significantly methylated in CD8 T~EM~ cells, whereas these regions remained predominantly unmethylated in naive, T~CM,~ and T~SCM~ CD8 T cells, consistent with the relative level of expression of those molecules in the different cell subsets ([Fig. 1, A and F](#fig1){ref-type="fig"}). Similar to the lymphoid-homing molecules, we observed striking differences in methylation status at the transcription factor loci for T-bet (*Tbx21*), eomesodermin (*Eomes*) and T cell--specific transcription factor (*TCF7*, coding for the Tcf1 protein; [Fig. 1 F](#fig1){ref-type="fig"} and Fig. S1 F), all of which have well-established roles in CD8 T cell effector and memory differentiation ([@bib32]; [@bib19], [@bib20]; [@bib13]; [@bib2]; [@bib33]; [@bib22]). Consistent with the relative level of gene expression, all memory CD8 T cells were generally demethylated at regions downstream of the transcriptional start site of T-bet and Eomes relative to that in naive T cells ([Fig. 1 F](#fig1){ref-type="fig"} and Fig. S2, A and B). Notably, several genes with established roles in regulating cellular plasticity, including *DNMT3A* and *TCF7* ([@bib8]; [@bib13]; [@bib40]), were progressively enriched for promoter methylation following a hierarchical order of least differentiated to most differentiated cells (naive \< T~SCM~ \< T~CM~ \< T~EM~; Fig. S1, F and G). Collectively, these data suggest that changes in epigenetic programs that occur during memory T cell differentiation are coupled to memory T cell subset specification and plasticity.

In contrast to the memory subset-specific DNA methylation programs found at lymphoid homing molecules and transcription factors, demethylation DMRs at loci of classically defined effector molecules, including *IFNγ*, Perforin, *GZMB*, and *GZMK*, were observed in all memory T cell subsets ([Fig. 1 F](#fig1){ref-type="fig"}). Of particular note was the level of demethylation at these loci in the long-lived T~SCM~ CD8 T cells. This observed state of epigenetic permissiveness is in striking contrast to a previous study examining in vitro--generated mouse T~SCM~ CD8 T cells, which reported that effector loci retained an epigenetic program that was not transcriptionally permissive ([@bib9]). Importantly, these new data are consistent with the hypothesis that T~SCM~ development may transit through an effector stage of cell differentiation.

To more broadly characterize DMRs linked to memory T cell longevity, we performed an ingenuity pathway analysis (IPA) of genes associated with naive versus T~SCM~ CD8 T cell DMRs. The IPA upstream regulator analysis identified STAT3 as being among the top potential regulators of the T~SCM~ DMR gene list (Fig. S1 H), further linking memory CD8 T cell development ([@bib10]) and the epigenetic poising of effector functions in long-lived memory T cells. We further assessed the relationship between changes in DNA methylation and memory T cell longevity by analyzing DMRs between shorter-lived T~EM~ and long-lived T~SCM~ CD8 T cells. Notably, the top canonical pathways associated with the methylated and demethylated DMRs, between T~EM~ and T~SCM~ cells, were involved in cellular proliferation, including the anti-proliferative role of TOB (Transducer of *ERBB2*) in T cell signaling and LXR/RXR activation (Fig. S1 I), which has been associated with reduction in T cell proliferation ([@bib5]). These data are consistent with T~EM~ having a reduced capactity for homeostatic proliferative capacity relative to T~SCM~ cells, and further indicate that the functional delineation among memory T cell subsets is coupled to changes in DNA methylation.

Demethylated effector loci in human memory CD8 T cells remain poised for expression during cytokine-driven proliferation {#s05}
------------------------------------------------------------------------------------------------------------------------

Having determined that the loci of several effector molecules in long-lived memory CD8 T cells contain an epigenetic program suggestive of transcriptional permissivity, we next sought to determine whether the effector-associated loci were poised for rapid gene expression in response to TCR stimulation. Naive and memory CD8 T cell subsets were purified and then cultured in the presence of anti-CD3/CD28 antibodies. mRNA was isolated longitudinally from the naive and memory CD8 T cell subsets at 0, 4, and 12 h after TCR stimulation, and the level of *IFNγ*, *GZMB*, and *PRF1* transcription was determined. Our results revealed that *GZMB* and *PRF1* transcription is rapidly induced in T~CM~ and T~SCM~ cells upon TCR ligation, whereas T~EM~ cells maintained a constitutively high level of expression after TCR activation (Fig. S3 A). Interestingly, the level of IFNγ mRNA was high in all resting memory CD8 T cell subsets, relative to naive cells (Fig. S3 A) but was further up-regulated upon stimulation of the memory subsets. Similar to the heightened kinetics for gene expression, TCR stimulation of the purified memory CD8 T cell subsets also resulted in a rapid increase in the production of GzmB in T~CM~ and T~SCM~ cells relative to that in naive T cells (Fig. S3 B). These results provide further evidence that the epigenetic status for the *IFNγ*, *PRF1*, and *GZMB* genes in human T~CM~ and T~SCM~ cells is coupled to the poising of effector molecule expression.

To further assess the ability of the memory CD8 T cell subsets to maintain a "poised-for-expression" gene-expression program during antigen-independent proliferation, we measured the expression of IFNγ in an in vitro model of cytokine-driven homeostatic cell proliferation. Purified naive and memory CD8 T cell subsets were labeled with the cell proliferation tracking dye CFSE and were then cultured in the presence of the homeostatic cytokines IL-7 and IL-15 for 7 d. Indeed, our results confirm those from prior studies showing that human memory CD8 T cell subsets have a hierarchical capacity to undergo cytokine-driven homeostatic proliferation, with T~SCM~ cells ([@bib15]) undergoing the most proliferation in the presence of both cytokines (naive \< T~EM~ \< T~CM~ \< T~SCM~; Fig. S3, C and D; [@bib37]; [@bib15]). We next measured the poised-recall response in cells that had undergone cytokine-driven proliferation by assessing the level of IFNγ protein in undivided and divided CD8 T cells after TCR stimulation. Quite strikingly, after 7 d in culture with IL-7 and IL-15, divided memory CD8 T cells retained the ability to rapidly express IFNγ protein after 4 h of TCR stimulation ([Fig. 2 A](#fig2){ref-type="fig"}). These results suggest that human memory CD8 T cells retain a gene-expression program during IL-7/IL-15--mediated proliferation that allows the cells to remain poised to elicit a rapid effector response.

![**Stable maintenance of poised effector programs during in vitro cytokine-driven proliferation of human memory CD8 T cell subsets.** (A, left) Recall response of undivided and divided, CFSE-labeled, naive, T~EM~, T~CM~, and T~SCM~ CD8 T cells expressing IFNγ during exposure to IL-7/IL-15 in culture for 7 d, followed by anti-CD3/CD28 stimulation (1:1 ratio) for 4 h. Gates indicate the percentage of undivided and divided cells. (right) Bar graph showing cumulative data from four independent experiments presented as the percentage means ± SEM. CD8 T cells expressing IFNγ during homeostatic proliferation after TCR stimulation (*n* = 4). (B) Freshly isolated CD8 T cell subsets were labeled with CFSE and subsequently maintained in culture in the presence of IL-7/IL-15 for 7 d. Undivided and divided cell subpopulations were then sorted, and genomic DNA was extracted for bisulfite sequencing analysis. (C, top) Representative bisulfite sequencing analysis of effector molecules in undivided and divided cells for each CD8 T cell subset. (bottom) Bar graph showing the percentage of CpG methylation (means ± SEM) at each site of the effector loci in undivided and divided, naive, T~EM~, T~CM~, and T~SCM~ cells (*n* = 4 healthy donors). Mann-Whitney *U* test was used. P \< 0.05 was considered significant. NS, not significant. Statistical comparison was based on the mean value of all CpG sites.](JEM_20161760_Fig2){#fig2}

Effector-associated DNA methylation programs are maintained during in vitro homeostasis {#s06}
---------------------------------------------------------------------------------------

Our WGBS methylation analyses of primary T cells serves as a "snapshot" of the epigenetic state of long-lived memory CD8 T cells but fails to reveal whether the DNA methylation programs are stable during homeostasis. Having validated the DNA methylation status of many DMRs identified from our WGBS analyses, including the DMRs identified in the *IFNγ* and *PRF1* loci ([Fig. 1 F](#fig1){ref-type="fig"} and Fig. S2), we proceeded to use our newly designed loci-specific assays to determine whether the methylation status would remain unchanged during in vitro, cytokine-driven homeostatic proliferation. Naive, T~EM~, T~CM~, and T~SCM~ CD8 T cell subsets were FACS purified, labeled with CFSE, and maintained in culture with IL-7 and IL-15 for 7 d. After 7 d, we then FACS purified the undivided and divided (≥3 rounds of cell division) fraction of cells and measured their DNA methylation status ([Fig. 2 B](#fig2){ref-type="fig"}). The *IFNγ* locus remained fully demethylated in all memory T cell subsets that had undergone cell division. In contrast, naive CD8 T cells that underwent more than three rounds of division retained a fully methylated *IFNγ* locus ([Fig. 2 C](#fig2){ref-type="fig"}). These data demonstrate that cell division alone is not sufficient to demethylate the IFNγ locus in naive cells; rather, the process of demethylation is coupled to additional events/stages of memory T cell differentiation.

Similar to the *IFNγ* locus, the demethylated status of CpGs within the *PRF1* locus remained unchanged in dividing CD8 T~EM~ cells ([Fig. 2 C](#fig2){ref-type="fig"}). This region of the *PRF1* locus was ∼50% demethylated in resting CD8 T~CM~ and T~SCM~ cells ([Fig. 1 F](#fig1){ref-type="fig"} and Fig. S3 E), which enabled us to test whether memory T cells undergo further demethylation through passive mechanisms (i.e., failure to propagate a methylation program during cell division). Remarkably, the 50% methylation status at the CpG sites in the T~CM~ and T~SCM~ cells was faithfully propagated for more than three rounds of cell division, demonstrating that acquired epigenetic programs at effector-associated loci can persist during cytokine-driven homeostatic proliferation.

CCR7 phenotypic conversion of long-lived T~SCM~ is coupled to changes in DNA methylation during homeostatic proliferation {#s07}
-------------------------------------------------------------------------------------------------------------------------

Antigen-independent phenotypic conversion of memory CD8 T cells has been previously observed during in vivo and in vitro homeostatic proliferation, but it remains openly debated whether this phenotypic conversion represents bona fide reprogramming of the cell's differentiation state ([@bib46]; [@bib25]; [@bib15]). Indeed, culturing naive, T~EM~, T~CM~, and T~SCM~ CD8 T cells with IL-7/IL-15 for 7 d results in down-regulation of CCR7 expression in both T~CM~ and T~SCM~ cells and a conversion to T~EM~-like cells ([Fig. 3, B and C](#fig3){ref-type="fig"}). This observation prompted us to investigate the status of DNA methylation in *CCR7* and CD62L DMRs under those conditions. We first confirmed that the CpG sites in the *CCR7* and CD62L DMRs were fully demethylated in both naive and T~SCM~ cells and were significantly methylated in T~EM~ cells isolated from six independently sorted samples ([Fig. 3 A](#fig3){ref-type="fig"}, bottom). Those data further substantiate the link between CCR7 and CD62L expression and the methylation status of the DMRs. We next measured the methylation status of *CCR7* and CD62L CpGs during cytokine-driven proliferation using the loci-specific assay. Naive and memory CD8 T cell subsets were again cultured in the presence of IL-7 and IL-15, and the methylation assay was performed on purified undivided and divided populations. Similar to our findings with the *IFNγ* and *PRF1* DMRs, the methylation status of the *CCR7* and CD62L DMR CpGs in divided naive CD8 T cells remained unchanged. However, we detected a significant increase in the methylation levels at the *CCR7* DMR in divided T~SCM~ cells ([Fig. 3 D](#fig3){ref-type="fig"}). These results provide compelling evidence that cytokine-induced developmental changes among long-lived memory CD8 T cells ([@bib15]) are coupled to the cell's ability to undergo selective epigenetic reprogramming. To further assess whether the mechanism(s) regulating the phenotypic and epigenetic conversion of T~SCM~ and T~CM~ cells was specific for the *CCR7* locus or was rather a general feature of these cells, we measured CD45RO expression in naive and memory CD8 T cell after IL-7/IL-15 culture for 7 d. In contrast to CCR7, CD45RO expression was not significantly changed after cell division of the naive and memory CD8 T cell subsets (Fig. S3, C and D). This stability in CD45RO expression was similar to the stability observed with the effector molecules and suggests that homeostasis-induced changes to epigenetic programming in T~CM~ and T~SCM~ is restricted to select loci.

![**Plasticity of tissue-homing programs during homeostatic proliferation of human memory CD8 T cell subsets.** (A, top) Representative DNA methylation profile analysis of *CCR7* and *SELL* DMRs from ex vivo isolated CD8 T cell subsets. Each horizontal line represents a clone, and each vertical line represents a CpG site. (bottom) Bar graphs showing the percentage of CpG methylation (means ± SEM) for each site (*n* = 4--5 independently sorted and analyzed healthy donor samples). Mann-Whitney *U* test was used. \*, P \< 0.03; and \*\*, P \< 0.01 were considered significant. NS, not significant. Statistical comparison was based on the mean value of all CpG sites. (B) CCR7 expression in undivided and divided, CFSE-labeled, naive, T~EM~, T~CM~, and T~SCM~ CD8^+^ T cells after exposure to IL-7/IL-15 in culture for 7 d. Gates indicate the percentage of undivided and divided cells (*n* = 4). (C) Paired analysis for CCR7 expression in undivided and divided populations of naive, T~EM~, T~CM~, and T~SCM~ CD8^+^ T cells after culture in IL-7/IL-15 for 7 d (*n* = 4 independently sorted and analyzed healthy donor samples). Paired Student's *t* test was used. \*\*, P \< 0.01 was considered significant. Error bars indicate SEM. (D, top) Representative bisulfite sequencing analysis of tissue-homing loci in undivided and divided cells for the indicated CD8 T cell subsets. (bottom) Bar graphs showing the percentage of CpG methylation (means ± SEM) for each site of the tissue-homing loci in undivided and divided, naive, T~EM~, T~CM~, and T~SCM~ cells (*n* = 5 independently sorted and analyzed healthy donor samples). Mann-Whitney *U* test was used. \*, P \< 0.03 was considered significant. NS, not significant. Statistical comparison was based on the mean value of all CpG sites.](JEM_20161760_Fig3){#fig3}

A defining feature of long-lived memory CD8 T cells (i.e., T~CM~ and T~SCM~) is their enhanced self-renewal compared with shorter-lived memory CD8 T cells (T~EM~). Given that we observed a dichotomy among the pool of T~SCM~ cells in their ability to retain a CCR7hi phenotype during in vitro homeostatic proliferation, we next asked whether down-regulation of CCR7 expression was associated with a reduced potential to maintain their parental cell identity. Tcf1 is a transcription factor downstream of the Wnt signaling pathway that has a critical role in regulating CD8 T cell self-renewal ([@bib47]; [@bib14]). Therefore, we further examined the relationship between Tcf1 expression (encoded by the *TCF7* gene) and promoter methylation in freshly isolated naive and memory CD8 T cells. Indeed, we observed that Tcf1 expression was inversely correlated with the methylation status of the *TCF7* promoter region (encoding for *Tcf1*; [Fig. 4, A and B](#fig4){ref-type="fig"}). We next performed loci-specific methylation profiling of the *TCF7* promoter among the daughter cells that arose from homeostatic proliferation of T~CM~ and T~SCM~ CD8 T cells to determine whether their phenotypic interconversion was coupled to stable changes in the epigenetic programs associated with a reduced capacity for self-renewal. Importantly, we observed that the divided T~CM~ and T~SCM~ CD8 T cells had indeed down-regulated Tcf1 protein expression ([Fig. 4 C](#fig4){ref-type="fig"}). Furthermore, the down-regulation of Tcf1 was coupled to an increase in *TCF7* promoter methylation ([Fig. 4 D](#fig4){ref-type="fig"}). These data suggest that the interconversion of long-lived memory CD8 T cells into shorter-lived memory CD8 T cells is coupled to epigenetic repression of transcriptional machinery that are critical for self-renewal.

![**Tcf1 expression is down-regulated during memory CD8 T cell in vitro homeostatic proliferation.** (A) Histogram showing Tcf1 expression levels in sorted, human, naive, T~EM~, T~CM~, and T~SCM~. (B, left) Representative bisulfite sequencing analysis of *TCF7* DMR in ex vivo isolated CD8 T cell subsets from one representative donor. Each horizontal line represents a clone, and each vertical line represents a CpG site. (right) Bar graph showing the mean percentage of CpG methylation (means ± SEM) for each site (*n* = 3 healthy donors) \*, P \< 0.05; and \*\*\*\*, P \< 0.0001 were considered significant. Unpaired Student's *t* test was used. Statistical comparison was based on the mean value of all CpG sites. (C) Mean fluorescence intensity (MFI) of Tcf1 in CCR7^lo^ and CCR7^hi^ naive and memory CD8 T cell subsets after 7 d of IL-7/IL-15 culture (*n* = 4 healthy donors). Mann-Whitney *U* test was used. \*, P \< 0.03 was considered significant. NS, not significant. Error bars indicate SEM. (D) Representative bisulfite sequencing analysis of *TCF7* in undivided and divided cells for the indicated CD8 T cell subsets.](JEM_20161760_Fig4){#fig4}

Memory CD8 T cells maintain effector and tissue homing-associated DNA methylation programs after adoptive transfer into transplant patients {#s08}
-------------------------------------------------------------------------------------------------------------------------------------------

Collectively, the results from our in vitro homeostasis studies established that DNA methylation programs associated with the heightened recall of effector functions are preserved over several rounds of cytokine-driven cell division, whereas programs coupled to homing markers broadly used to delineate memory T cell subsets can be modified. Although the effector-associated epigenetic programs exhibited remarkable stability under conditions of in vitro homeostasis, a lingering question is whether such stability occurs in vivo. One of the main challenges of studying in vivo human T cell homeostasis is the difficulty of tracking and reisolating adoptively transferred T cells from the recipient because of their low frequency in circulation and the lack of congenic markers to distinguish donor versus recipient T cells. To overcome these challenges we took advantage of a novel T cell depletion strategy used at our institution, which selectively depletes CD45RA^+^ cells in haploidentical donor grafts for hematopoietic cell transplantation, thereby providing adoptive transfer of numerous donor memory cells at the time of transplantation ([@bib41]). This infusion of polyclonal total T~CM~ and T~EM~ memory T cells provides a unique opportunity to assess the stability of epigenetic programs in human memory CD8 T cells during in vivo homeostatic proliferation.

Using the transplantation protocol, we assessed the stability of DNA methylation programs in memory CD8 T cells that underwent antigen-independent expansion in vivo. Five blood samples from hematopoietic cell transplant recipients were selected for analyses based on the criteria of 100% donor chimerism among the reconstituted immune cells after infusion, and no signs of immunologic responses to infection ([Fig. 5 A](#fig5){ref-type="fig"}). The phenotype of donor T cells was examined before CD45RO enrichment for adoptive transfer and then measured again ∼2 mo after adoptive transfer and expansion in the patient. CD8 T cells isolated from the blood of recipients were strikingly void of cells exhibiting a naive phenotype, indicating that enrichment before infusion indeed excluded CD45RO^−^ cells ([Fig. 5 A](#fig5){ref-type="fig"}). The expanded CD8 T cells predominantly exhibited a T~EM~ phenotype, despite the transfer of both T~CM~ and T~EM~ memory CD8 T cell ([Fig. 5 B](#fig5){ref-type="fig"}, top) and also expressed higher levels of Ki67 indicating that they had recently proliferated ([Fig. 5 B](#fig5){ref-type="fig"}, bottom). Notably, the memory CD8 T cells isolated from the recipients retained a high degree of clonal diversity and had only a modest increase in the level of PD-1 expression, further supporting the conclusion that polyclonal expansion of memory T cells in those patients did not occur because of an encounter with pathogen-associated antigens ([Fig. 5 C](#fig5){ref-type="fig"}).

![**In vivo stability of effector-associated programs in memory CD8 T cells from immunocompromised patients after donor lymphocyte infusion.** (A) Schematic representation for the donor lymphocyte infusion protocol showing infusion of CD45RO^+^ memory T cells from healthy, haploidentical donors into bone marrow transplant (BMT) recipient. Representative FACS plots show the frequency of naive, T~EM~, and T~CM~ CD8 T cells in PBMCs from a healthy, haploidentical donor and a patient on day 32 after transplant. (B, top) Bar graph showing the percentage of T~EM~ cells among CD45RO^+^ CD8 T cells (means ± SEM) in donor and bone marrow transplant patient (*n* = 5). (bottom) Ki-67 staining for T~EM~ CD8 T cells from a healthy, haploidentical donor and a patient on day 53 after transplant. (C) Mean fluorescence intensity (MFI) of PD-1 in naive and T~EM~ CD8 T cells from a healthy, haploidentical donor versus T~EM~ from a bone marrow transplant patient (*n* = 4). Error bars indicate SEM. \*, P \< 0.02 was considered significant. (D) Representative FACS plots showing pre- and postsort purity for T~EM~ and T~CM~ in haploidentical donor and transplant patient. (E, top) Representative bisulfite sequencing analysis of effector-associated loci in donor naive and T~EM~ CD8 T cells and BMT patient T~EM~ CD8 T cells. (bottom) Bar graph showing the percentage of CpG methylation (means ± SEM) for each site of tissue homing--associated loci in naive and T~EM~ CD8 T cells from both donor and patient. (F, top) Representative bisulfite sequencing analysis of tissue homing--associated loci in donor naive and T~EM~ CD8 T cells and patient T~EM~ CD8 T cells. (bottom) Bar graph showing the percentage of CpG methylation (means ± SEM) for each site of tissue homing--associated loci in naive and T~EM~ CD8 T cells from both donor and patient (*n* = 4 healthy donors and recipients). Mann-Whitney *U* test was used.](JEM_20161760_Fig5){#fig5}

Having established that most T cells isolated from the PBMCs of recipients retained a memory phenotype and originated from the donor (chimerism was 100% based on VNTR \[variable number tandem repeat\]), we next sought to determine the DNA methylation status of effector and homing-associated DMRs in those cells. Loci-specific DNA methylation profiling of the *IFNγ* and *PRF1* DMRs in purified donor T~EM~ CD8 T cells (pretransfer) and T~EM~-phenotyped cells isolated from the recipients, confirmed that the promoters of those effector-associated genes remained demethylated during in vivo memory T cell reconstitution of the recipients ([Fig. 5, D and E](#fig5){ref-type="fig"}). These data unambiguously establish that memory T cells can maintain a transcriptionally permissive epigenetic program at effector-associated loci during in vivo antigen-independent proliferation ([Fig. 5 E](#fig5){ref-type="fig"}). Additionally, the *CCR7* and CD62L DMRs were heavily methylated in the recipient memory T cells when compared with the input donor memory T cells ([Fig. 5 F](#fig5){ref-type="fig"}). Therefore, despite the donor infusion containing both T~CM~ and T~EM~ CD8 T cells, the recipient was found to have primarily T~EM~ CD8 T cells. It is quite possible that the absence of T~CM~-like CD8 T cells from the circulation of the recipients' samples was due to selective death of the transferred T~CM~ or to selective homing to the lymphoid tissue. Yet, a more exciting possibility is that these data represent in vivo evidence of human memory CD8 T cell subset interconversion. Such a conversion of T~CM~ CD8 T cells into cells with a T~EM~ phenotype is consistent with our in vitro results showing that γ-chain cytokines promote the conversion of long-lived memory CD8 T cells into T~EM~ memory CD8 T cells ([Fig. 3, B and C](#fig3){ref-type="fig"}).

Over the lifetime of an organism, memory T cell homeostasis ensures protection against previously encountered pathogens and is achieved, in part, by a fine balance between the death and proliferation of those cells ([@bib31]; [@bib17]). This balance is largely orchestrated by the common γ-chain cytokines IL-7 ([@bib27]; [@bib16]), which is essential for cell survival, and IL-15, which promotes cell cycling ([@bib44]; [@bib3]; [@bib38]). Our study establishes that in vivo preservation of effector potential during cytokine-mediated homeostasis of human memory CD8 T cells is coupled to the ability of the cell to propagate acquired DNA methylation programs to newly generated daughter cells. Moreover, these results reveal that stabilization of epigenetic programming occurs in a loci-specific manner, providing new insight into the mechanisms regulating memory T cell subset interconversion ([@bib29]). Broadly, these data highlight epigenetic programming as a mechanism that memory T cells use to strike a balance between remaining adaptive to their current and future environments and retaining a history of past events.

Materials and methods {#s09}
=====================

Isolation of human CD8 T cells from healthy donor blood {#s10}
-------------------------------------------------------

This study was conducted with approval from the Institutional Review Board (IRB) of St. Jude Children's Research Hospital. PBMCs were collected through the St. Jude Blood Bank, and samples for WGBS were collected under IRB protocol XPD15-086. PBMCs were purified from a platelet-apheresis blood unit using a density gradient. In brief, blood was diluted 1:2.5 using sterile Dulbecco's PBS (Thermo Fisher Scientific). The diluted blood was then overlayed with Ficoll-Paque PLUS medium (GE Healthcare) to a final dilution of 1:2.5 (Ficoll/diluted blood). The gradient was centrifuged at 400 *g* with no brake for 20 min at room temperature. The PBMC interphase layer was collected, washed with 2% FBS/1 mM EDTA PBS buffer, and centrifuged at 400 *g* for 5 min. Total CD8 T cells were enriched from PBMCs with the EasySep human CD8 negative-selection kit (STEMCELL Technologies). T cells were collected from the peripheral blood of bone marrow transplant patients enrolled in an IRB-approved protocol (registered at ClinicalTrials.gov, Identifier: NCT01807611). All donors provided informed consent for collection of the blood samples used for the in vivo analyses. Donor chimerism was determined using CLIA-certified VNTR analysis.

Isolation and flow cytometric analysis of naive and memory CD8 T cell subsets {#s11}
-----------------------------------------------------------------------------

After enrichment of CD8 T cells, naive and memory CD8 T cell subsets were sorted using the following markers, as previously described ([@bib15]; [@bib28]). Naive CD8 T cells were phenotyped as live CD8^+^~,~ CCR7^+^, CD45RO^−^, CD45RA^+^, and CD95^−^ cells. CD8 T~EM~ cells were phenotyped as live CD8^+^, CCR7^−^, and CD45RO^+^ cells. CD45RA staining was included in our analysis to exclude terminally differentiated T~EMRA~ CD8 T cells, defined as CD8^+^, CCR7^−^, CD45RO^−^, and CD45RA^+^ cells. T~CM~ cells were phenotyped as live CD8^+^, CCR7^+^, and CD45RO^+^ cells. T~SCM~ cells were phenotyped as live CD8^+^, CCR7^+^, CD45RO^−^, and CD95^+^ cells. Sorted cells were checked for purity (i.e., samples were considered pure if \>90% of the cells had the desired phenotype). GzmB expression was measured in individually sorted naive or memory CD8 T cell subsets that were subsequently stimulated with human CD3/CD28 human T cell activator Dynabeads (Invitrogen) at a 1:1 ratio. After ∼18 h of incubation at 37°C and 5% CO~2~, cells were harvested for cell-surface staining followed by intracellular staining.

Genomic methylation analysis {#s12}
----------------------------

DNA was extracted from the sorted cells by using a DNA-extraction kit (QIAGEN) and then bisulfite treated using an EZ DNA methylation kit (Zymo Research), which converted all unmethylated cytosines to uracils and protected the methylated cytosines from a deamination reaction. The bisulfite-modified DNA-sequencing library was generated using the EpiGnome kit (Epicentre) per the manufacturer's instructions. Bisulfite-modified DNA libraries were sequenced using an Illumina HiSeq system. Sequencing data were aligned to the HG19 genome by using BSMAP software ([@bib50]). Differential-methylation analysis of CpG methylation among the datasets was determined with a Bayesian hierarchical model to detect regional methylation differences with at least three CpG sites ([@bib49]). To perform loci-specific methylation analysis, bisulfite-modified DNA was PCR amplified with locus-specific primers. The PCR amplicon was cloned into a pGEMT easy vector (Promega) and then transformed into XL10-Gold ultracompetent bacteria (Agilent Technologies). Bacterial colonies were selected using a blue/white X-gal selection system after overnight growth, the cloning vector was then purified from individual colonies, and the genomic insert was sequenced. After bisulfite treatment, the methylated CpGs were detected as cytosines in the sequence, and unmethylated CpGs were detected as thymines in the sequence by using BISMA software ([@bib35]).

In vitro homeostatic proliferation {#s13}
----------------------------------

Sorted naive CD8 T cells and memory CD8 T cell subsets were labeled with CFSE (Life Technologies) at a final concentration of 2 µM. CFSE-labeled cells were maintained in culture in RPMI containing 10% FBS, penicillin-streptomycin, and gentamycin-containing IL-7/IL-15 at a final concentration of 25 ng/ml each. After 7 d of incubation at 37°C and 5% CO~2~, undivided and divided cells (third division and higher) were sorted. Sorted cells were checked for purity (\>90%). To determine whether the effector-recall response was maintained, we stimulated naive and memory CD8 T cell subsets with anti-CD3/CD28 beads (1:1 ratio) for 4 h in the presence of GolgiStop and GolgiPlug (BD), after a 7 d exposure to IL-7/IL-15 in culture, and then examined the levels of IFNγ protein expression by intracellular staining.

Quantitative transcriptional analysis {#s14}
-------------------------------------

Total RNA was extracted from naive and memory CD8 T cell subsets with the RNeasy plus micro kit (QIAGEN). RNA was reverse transcribed into cDNA with Superscript III reverse transcription (Roche). Real-time PCR was performed on a CFX96 Real-Time System (Bio-Rad Laboratories). Relative quantities of mRNA were determined with the Syber Select Master Mix CFX (Roche). Primer sequences are provided in the Supplemental Materials. The levels of mRNA for each gene were normalized to that of β-actin, and the fold increase in signal over that of the naive CD8 T cells was determined by the ΔΔct calculation.

Human primer sequences for loci-specific bisulfite sequencing {#s15}
-------------------------------------------------------------

*TBX21* forward, 5′-GGTTAGTGTAGTAAAGTTTGTAGGG-3′ and reverse, 5′-CCTCTAAAATCCAACATAACCTTCTCC-3′; *EOMES* forward, 5′-ATATGTAGGGTGTGAGTAGAGAAGAGG-3′ and reverse, 5′-CCAAAAACCCTTCCCACCTAAAAAAC-3′; *ID2* forward, 5′-GAAATATATGTATATAAAGTATATTAAAAG-3′ and reverse, 5′-CTACCTCAATCTCTACCTCCTTTAC-3′; *SELL* forward, 5′-GGTATTTATAATTTGTATTAAATATTTAG-3′ and reverse, 5′-CCTATTATATAAAAAAAACACTAAATTTC-3′; *CCR7* forward, 5′-GAGAGAATGAAAGTTATTTTATTTG-3′ and reverse, 5′-CTAATTAATACAAAATAATTACTATCC-3′; *PD-1* forward, 5′-GCCACAGCAGTGAGCAGAGA-3′ and reverse, 5′-CTAAGGATGGGATGAGCCCC-3′; *CD244* (2B4) forward, 5′-GTTTTTCAAGGTGTATTAGGGTAAAG-3′ and reverse, 5′-CCAAACTCCTATAACATCTAAATAAC-3′; *CTLA4* forward, 5′-GGTAAAATTTTAATTTGGTTTGGTTGG-3′ and reverse, 5′-CTATCCTTTCCCTCTTAAATCACTTCC-3′; *LAG3* forward, 5′-GGGAGGTTCAGTTTTTGGGTTTGTTG-3′ and reverse, 5′-CTAACTAATACTACCAAATAACCCC-3′; *EZH2* forward, 5′-GTAAATATTTTTACATTTTGTAGA-3′ and reverse, 5′-CCTATTTAATTATATCTACTACTAC-3′; *IFNγ* forward, 5′-GATTTAGAGTAATTTGAAATTTGTGG-3′ and reverse, 5′-CCTCCTCTAACTACTAATATTTATACC-3′; *PRF1* forward, 5′-GTGTGATTTATGAGATATGATGTTATATG-3′ and reverse, 5′-CCACTTCCTACTCAACCTACATCCCAC-3′; *TCF7* forward, 5′-AGGGGAGTTGTTGATTGTA-3′ and reverse, 5′-TCCACAACAACTCAACCCTAAAAA-3′; and *PTPRC* (CD45RC) forward, 5′-GTTGAGGTTTTTGGTATGG-3′ and reverse, 5′-CCTCAACCTCCCAATATTATAAC-3′.

Online supplemental material {#s16}
----------------------------

Fig. S1 shows bioinformatics analyses of our genome-wide naive and memory CD8 T cell DNA methylation datasets. Fig. S2 shows loci-specific, bisulfite sequencing DNA methylation validation of various DMRs identified in the WGBS datasets of naive and memory CD8 T cells, including transcription factors and inhibitory receptors. Fig. S3 shows data demonstrating that memory CD8 T cells are poised to elicit effector molecule expression, have demethylated effector loci, and retain CD45RO expression levels during IL-7/IL-15--induced proliferation.
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